Chest
Volume 151, Issue 6, June 2017, Pages 1207-1208
EditorialImproving the Diagnosis of Latent TB Infection: Tools for TB Elimination?
References (11)
- et al.
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon gamma release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial
Lancet Respir Med
(2017) - et al.
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study
Lancet Respir Med
(2017) - et al.
Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention
Int J Tuberc Lung Dis
(2015) - et al.
Prospects for tuberculosis elimination
Annu Rev Public Health
(2013) Towards tuberculosis elimination: an action framework for low-incidence countries
(2014)
There are more references available in the full text version of this article.
Cited by (5)
New Research Strategies in Latent Tuberculosis Infection
2021, Archivos de BronconeumologiaFormulation and Validation of Recombinant Antigens CFP10 and ESAT6 for Tuberculosis Diagnosis
2021, Brazilian Archives of Biology and TechnologyModeling and analysis of barriers in controlling TB: developing countries' perspective
2021, International Journal of Health GovernanceLatent tuberculosis infection (LTBI) and its potential targets: An investigation into dormant phase pathogens
2019, Mini-Reviews in Medicinal Chemistry
FINANCIAL/NONFINANCIAL DISCLOSURES: None declared.
© 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.